文献速递功能神经外科

复发或难治性三叉神经痛的再次手术:系统评价与Meta分析

Repeat Surgery for Recurrent or Refractory Trigeminal Neuralgia: A Systematic Review and Meta-Analysis.
PubMed 文献 · World Neurosurg · 2024-02-24

系统评价与Meta分析纳入61项研究、68个治疗组、2165例经典或特发性三叉神经痛成人患者,比较再次显微血管减压术(MVD)、经皮神经根切断术(PR)与立体定向放射外科(SRS)的疼痛缓解。末次随访平均术后2.99年时,MVD、PR与SRS的完全疼痛缓解比例分别为0.57、0.60与0.35,SRS显著较低;MVD与PR在初始及长期疼痛缓解上均优于SRS。

要点

  • 再次手术后平均随访2.99年,MVD与PR的完全疼痛缓解比例分别为0.57与0.60,SRS为0.35。
  • 初始完全疼痛缓解:MVD为0.82,PR为0.68,SRS为0.41。
  • SRS的完全疼痛缓解比例显著低于MVD与PR,结果可辅助手术决策。

核心结论

  • 再次手术后平均随访约3年,约半数三叉神经痛患者维持完全疼痛缓解。
  • 治疗难治性或复发性三叉神经痛时,MVD与PR在初始及末次随访长期疼痛缓解上均优于SRS。

研究设计与样本

  • PRISMA系统评价与Meta分析,纳入经典或特发性三叉神经痛成人再次手术研究。
  • 共筛查1299条记录,纳入61项研究、68个治疗组(MVD 29组、PR 14组、SRS 25组),合计2165例患者。
  • 采用多变量混合效应比例Meta回归分析完全疼痛缓解与充分疼痛缓解。

主要发现

  • 再次手术后初始完全疼痛缓解的合并比例为68.8%。
  • 末次随访平均术后2.99年时,合并样本中49.6%达到完全疼痛缓解。
  • 末次随访完全疼痛缓解比例:MVD 0.57(95%CI 0.51-0.62),PR 0.60(95%CI 0.52-0.68),SRS 0.35(95%CI 0.30-0.41),SRS显著较低。
  • 初始完全疼痛缓解比例:MVD 0.82(95%CI 0.78-0.85),PR 0.68(95%CI 0.6-0.76),SRS 0.41(95%CI 0.35-0.48)。

临床怎么用

  • 作者认为,上述发现可为难治性或复发性三叉神经痛患者的手术决策提供参考。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Surgery can effectively treat Trigeminal neuralgia (TN), but postoperative pain recurrence or nonresponse are common. Repeat surgery is frequently offered but limited data exist to guide the selection of salvage surgical procedures. We aimed to compare pain relief outcomes after repeat microvascular decompression (MVD), percutaneous rhizotomy (PR), or stereotactic radiosurgery (SRS) to determine which modality was most efficacious for surgically refractory TN. METHODS: A PRISMA systematic review and meta-analysis was performed, including studies of adults with classical or idiopathic TN undergoing repeat surgery. Primary outcomes included complete (CPR) and adequate (APR) pain relief at last follow-up, analyzed in a multivariate mixed-effect meta-regression of proportions. Secondary outcomes were initial pain relief and facial numbness. RESULTS: Of 1299 records screened, 61 studies with 68 treatment arms (29 MVD, 14 PR, and 25 SRS) comprising 2165 patients were included. Combining MVD, PR, and SRS study data, 68.8% achieved initial CPR after a repeat TN procedure. On average, 49.6% of the combined sample of MVD, PR, and SRS had CPR at final follow-up, which was on average 2.99 years postoperatively. The proportion (with 95% CI) achieving CPR at final follow-up was 0.57 (0.51-0.62) for MVD, 0.60 (0.52-0.68) for PR, and 0.35 (0.30-0.41) for SRS, with a significantly lower proportion of pain relief with SRS. Estimates of initial CPR for MVD were 0.82 (0.78-0.85), 0.68 for PR (0.6-0.76), and 0.41 for SRS (0.35-0.48). CONCLUSIONS: Across MVD, PR, and SRS, about half of TN patients maintain complete CPR at an average follow-up time of 3 years after repeat surgery. In treating refractory or recurrent TN, MVD and PR were superior to SRS in both initial pain relief and long-term pain relief at final follow-up. These findings can inform surgical decision-making in this challenging population.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Rheaume AR, Pietrosanu M, Ostertag C, et al. Repeat Surgery for Recurrent or Refractory Trigeminal Neuralgia: A Systematic Review and Meta-Analysis. World Neurosurg. 2024. PMID: 38403014. doi:10.1016/j.wneu.2024.02.097

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。